BABA vs CYD

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

CYD presents a compelling value opportunity with a stable Piotroski F-Score of 5/9 and a current price ($42.24) trading very close to its Graham Number ($40.87) and well below its intrinsic value ($61.95). The company exhibits explosive earnings growth (109.1% YoY) and an exceptionally low PEG ratio of 0.33, suggesting significant undervaluation relative to its growth trajectory. While technical trends are currently bearish and profit margins are thin, the fundamental valuation metrics and analyst price targets ($55.54) point toward strong upside potential.